Stericycle (NASDAQ:SRCL) Releases FY 2024 Earnings Guidance

Stericycle (NASDAQ:SRCL) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 2.200-2.500 for the period, compared to the consensus estimate of 2.330. The company issued revenue guidance of -.

Stericycle Trading Down 4.4 %

Shares of SRCL traded down $2.18 during midday trading on Thursday, reaching $47.69. The stock had a trading volume of 209,935 shares, compared to its average volume of 450,583. Stericycle has a 52 week low of $37.78 and a 52 week high of $57.06. The company has a quick ratio of 0.94, a current ratio of 0.94 and a debt-to-equity ratio of 0.51. The firm’s 50 day moving average price is $51.50 and its 200-day moving average price is $48.16.

Stericycle (NASDAQ:SRCL) last announced its earnings results on Wednesday, February 28th. The business services provider reported $0.54 EPS for the quarter, beating the consensus estimate of $0.47 by $0.07. Stericycle had a positive return on equity of 7.06% and a negative net margin of 0.80%. The business had revenue of $652.00 million during the quarter, compared to the consensus estimate of $657.99 million. During the same period in the prior year, the business posted $0.60 earnings per share. Stericycle’s revenue was down 2.7% compared to the same quarter last year. On average, equities analysts anticipate that Stericycle will post 2.32 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on SRCL shares. Truist Financial increased their price objective on Stericycle from $50.00 to $57.00 and gave the stock a hold rating in a research note on Thursday, February 29th. Royal Bank of Canada reissued an outperform rating and issued a $69.00 price objective on shares of Stericycle in a research note on Thursday, March 7th. Stifel Nicolaus increased their price objective on Stericycle from $70.00 to $75.00 and gave the stock a buy rating in a research note on Thursday, February 29th. StockNews.com lowered Stericycle from a buy rating to a hold rating in a research report on Tuesday, April 2nd. Finally, Wells Fargo & Company upped their target price on Stericycle from $40.00 to $48.00 and gave the stock an underweight rating in a research report on Friday, March 1st. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of Hold and a consensus target price of $62.25.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.